Find latest AML videos · 100+ videos
ASH 2022 Conference Coverage
G

ASH 2022: Venetoclax Combined With Cladribine, Idarubicin, Cytarabine (CLIA) as Induction Therapy in Pts With Newly Diagnosed AML and High-Risk MDS

By ASH 2022 Conference Coverage FEATURING Gautam Borthakur
By ASH 2022 Conference Coverage FEATURING Gautam Borthakur
175 views
January 28, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

Related Videos

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.5K views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

644 views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

717 views
17:51

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Indy Hematology Review

H. Erba

893 views
19:21

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

520 views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

746 views
27:26

Where I Use Azacitidine and Venetoclax in AML: Present and Future

SOHO Brazil 2024

J. Lancet

465 views
28:02

2024 Updates in AML

University of Colorado Division of Hematology

C. McMahon

753 views
22:30

Emerging Treatment Options for AML in 2024

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

A. Perl

722 views
14:32

Summary of Recent Updates in MDS

Vanderbilt University Medical Center (VUMC)

S. Ball

434 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

901 views
09:51

MRD Testing in Leukemias: When Negativity Is a Positive Thing

i3 Health

N. S. Raje

472 views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

397 views
48:04

Integrating Targeted Therapies in AML

Icahn School of Medicine at Mount Sinai

H. Kantarjian

422 views
14:39

Immunotherapies in Acute Leukemias: 2024 Update

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

C. Lai

520 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

220 views
14:58

ASCO® 2024 Summary: "Optimal Treatment Strategies for Younger Patien…

2024 ASCO® Annual Meeting Insights Hub

C. McMahon

292 views
19:10

SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center

5th SOHO Italy Annual Conference

H. Kantarjian

598 views
16:55

Making Sense of the New Classification Systems for MDS in 2024

Moffitt Cancer Center

R. Komrokji

444 views
AUTOPLAY